Silver Book Fact

Therapy that keeps blood glucose levels as close to normal as possible in type 1 diabetics, reduces damage to the eyes by 76%. Experts believe that these results can also be applied to type 2 diabetics.

Lasker R. The Diabetes Control and Complications Trial: Implications for policy and practice. NEJM. 1993; 329. http://www.nejm.org/doi/full/10.1056/NEJM199309303291410

Reference

Title
The Diabetes Control and Complications Trial: Implications for policy and practice
Publication
NEJM
Publication Date
1993
Authors
Lasker R
Pages
1035-6
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The initiation of insulin therapy in the management of type 2 diabetes involves an approximate 10% increase in total health care expenditures initially, although this is offset by the consistent…  
  • Treatment of diabetes with medication and other therapy saves $685-$950 in health care costs per patient within 1-2 years.  
  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring, and collaborative drug therapy management…  
  • Laser Treatment for DR
    Laser treatment of PDR can reduce the 5-year risk of blindness by 90%, and the risk of visual loss from DME by 50%.